New Software Defined Wide Area Network product seamlessly binds multiple access technologies into single logical path for improved performance

REFFIND (ASX: RFN) appointed Value Added Reseller and exclusive Network Operator in territory

Targeting New Diagnostic Tests and Improved Drug Development

Asia Opportunities, Technology and Belt and Road Collaboration Spotlighted

SYDNEY, AUSTRALIA, May 19, 2017 - (ACN Newswire) - Faecal Microbiota Transplantation (FMT) leader Professor Thomas Borody (MD, PhD) has called for a national faecal bank to fight drug resistant and epidemic diseases in hospitals and clinics across the cou

YPO, the world's premier leadership organization for chief executives, will kick off the second annual Innovation Week in Melbourne, Australia, with the two-day signature event, Igniting Innovation in Australia.

SYDNEY, Australia and SEOUL, Korea - Asia Pacific specialist CRO Novotech announced today it has signed a Memorandum of Understanding (MOU) with South Korea's largest medical institution - The Asan Medical Center's (AMC) Clinical Trial Center.

PERTH, W.

Proteomics, the leader in predictive diagnostics for DKD, advancing deals with commercialisation partners in Singapore and China this week

Sydney, Australia, Mar 4 -  Frost & Sullivan today released its latest white paper, 'Asia: Preferred Destination for Clinical Trials', with Asia Pacific specialist CRO Novotech.